IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease
National Cancer Institute (NCI)monoclonal_antibodyPhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
(+)-VINCRISTINE National Cancer Institute (NCI) | Phase 1/2 | CCC |
PREDNISONE TABLETS National Cancer Institute (NCI) | Phase 1/2 | CCC |
Inno-206 National Cancer Institute (NCI) | Phase 1/2 | CCC |
ETOPOSIDE National Cancer Institute (NCI) | Phase 1/2 | CCC |
Pomalidomide National Cancer Institute (NCI) | Phase 1/2 | CCC |
Cyclophosphamide National Cancer Institute (NCI) | Phase 1/2 | CCC |
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →